Meeting
2017 ASCO Annual Meeting
Risk stratification by detection of clonal circulating plasma cells (CPCs) by multi-parametric flow cytometry (MFC) in light chain amyloidosis (AL).
Authors
Surbhi Sidana
Mayo Clinic, Rochester, MN
Surbhi Sidana , Nidhi Tandon , Angela Dispenzieri , Morie A. Gertz , Francis Buadi , Martha Lacy , David Dingli , Amie L. Fonder , Suzanne R. Hayman , Miriam A. Hobbs , Yi Lisa Hwa , Prashant Kapoor , Robert A. Kyle , Nelson Leung , Ronald S. Go , John Anthony Lust , Stephen J. Russell , S. Vincent Rajkumar , Shaji Kumar , Wilson I. Gonsalves
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies—Plasma Cell Dyscrasia
Sub Track
Plasma Cell Disorders
Citation
J Clin Oncol 35, 2017 (suppl; abstr 8047)
DOI
10.1200/JCO.2017.35.15_suppl.8047
Abstract #
8047
Poster Bd #
373
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Quantification of circulating clonal plasma cells (cPCs) via multiparametric flow cytometry (MFC) to identify patients with smoldering multiple myeloma (SMM) at high risk of progression.
First Author: Wilson I. Gonsalves
Poster
2016 ASCO Annual Meeting
Association of abnormal molecular markers with clonal plasma cell burden in light chain amyloidosis.
First Author: Lindsay Hammons
Poster
2015 ASCO Annual Meeting
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in multiple myeloma.
First Author: Wilson I. Gonsalves
Poster
2024 ASCO Annual Meeting
From criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity.
First Author: Mengmeng Ji